Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
06/14/2001 | WO2001042246A2 PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS |
06/14/2001 | WO2001042245A1 Neurotrophic bicyclic diamides |
06/14/2001 | WO2001042243A2 Protein kinase inhibitors |
06/14/2001 | WO2001042242A1 Antibacterial heterobicyclic substituted phenyl oxazolidinones |
06/14/2001 | WO2001042228A1 Macrocyclic compounds and their use |
06/14/2001 | WO2001042213A1 Urea compounds having muscarinic receptor antagonist activity |
06/14/2001 | WO2001042212A1 Carbamate derivatives having muscarinic receptor antagonist activity |
06/14/2001 | WO2001042211A2 Detection of transmembrane potentials by optical methods |
06/14/2001 | WO2001042208A1 Cycloamine ccr5 receptor antagonists |
06/14/2001 | WO2001041768A2 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
06/14/2001 | WO2001027111A3 Bicyclic imidazo-3-yl-amine derivatives |
06/14/2001 | WO2001027101A3 Anhydrous salt |
06/14/2001 | WO2001002373A8 Dihydrobenzodiazepins and their use for treating dyslipidemia |
06/14/2001 | US20010003736 Photobleaching compositions comprising mixed metallocyanines |
06/14/2001 | CA2394891A1 Substituted phthalocyanines and their precursors |
06/14/2001 | CA2394580A1 Macrocyclic compounds and their use |
06/14/2001 | CA2393562A1 Detection of transmembrane potentials by optical methods |
06/14/2001 | CA2384982A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
06/13/2001 | EP1106210A2 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
06/13/2001 | EP1106180A1 Use of hymenialdisine or derivatives thereof in the manufacture of medicaments |
06/13/2001 | EP1105728A1 Modulating multiple lineage kinase proteins |
06/13/2001 | EP1105396A1 Process for the preparation of pyrrolo[2,3-d]pyrimidines |
06/13/2001 | EP1105393A1 Bicyclic piperidine and piperazine compounds having 5-ht 6? receptor affinity |
06/13/2001 | EP1105392A1 Process for the preparation of imidazodiazepine intermediates |
06/13/2001 | EP1105368A1 Photoactivatable bases containing nitrogen |
06/13/2001 | EP1105120A2 NON-PEPTIDE GnRH AGENTS, METHODS AND INTERMEDIATES FOR THEIR PREPARATION |
06/13/2001 | EP0805812B1 Bicyclic substituted hexahydrobenz(e)isoindole alpha-1- adrenergic antagonists |
06/13/2001 | EP0666858B1 5-arylindole derivatives and their use as serotonin (5-ht 1) agonists |
06/13/2001 | CN1299362A Pyrazolo [1,5-a] pyrimidine derivatives |
06/13/2001 | CN1067075C Pyrrolo-gyrrolone used as neutrophil elastase inhibitor |
06/12/2001 | US6245769 Heterocyclyl-substituted ring-fused pyridines and pyrimidines as corticotropin releasing hormone(CRH) antagonists, useful for treating CNS and stress-related disorders |
06/12/2001 | US6245759 Tyrosine kinase inhibitors |
06/12/2001 | US6245449 Material for organoelectroluminescence device and use thereof |
06/12/2001 | CA2072123C Inhibitors of purine nucleoside phosphorylase |
06/07/2001 | WO2001040874A1 Use of a composition in stereolithography |
06/07/2001 | WO2001040774A1 Method of determining absolute configuration of chiral compound |
06/07/2001 | WO2001040234A1 Porphyrin compound |
06/07/2001 | WO2001040233A1 Nitroimidazole-supporting porphyrin complex |
06/07/2001 | WO2001040232A1 Chlorophyll and bacteriochlorophyll esters, and their preparation |
06/07/2001 | WO2001040231A1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
06/07/2001 | WO2001040230A1 Pyrazolopyrazines and their use as adenosine antagonists |
06/07/2001 | WO2001040229A2 Method for producing epinastine hydrochloride in the high-melting crystal modification |
06/07/2001 | WO2001040225A1 Remedies or preventives for frequent urination or urinary incontinence |
06/07/2001 | WO2001040185A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
06/07/2001 | WO2001039777A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
06/07/2001 | WO1999063940A3 INHIBITORS OF H+K+-ATPase |
06/07/2001 | DE19958460A1 Verfahren zur Herstellung von Epinastine-Hydrochlorid in der hochschmelzenden Kristallmodifikation Process for preparing epinastine hydrochloride in the high-melting crystal modification |
06/07/2001 | DE19948436A1 New azolo-fused bicyclic imidazolyl-amine compounds, useful as alpha-2 adrenergic receptor ligands and analgesics |
06/07/2001 | DE19948434A1 Substanzbibliothek enthaltend bicyclische Imidazo-5-amine und/oder bicyclische Imidazo-3-amine Substance library containing bicyclic imidazo-5-amines and / or bicyclic imidazo-3-amine |
06/07/2001 | CA2393179A1 Compounds specific to adenosine a1 a2a, and a3 receptors and uses thereof |
06/07/2001 | CA2392989A1 Chlorophyll and bacteriochlorophyll esters, their preparation and pharmaceutical compositions comprising them |
06/07/2001 | CA2389368A1 Compounds, compositions, and methods for stimulating neuronal growth and elongation |
06/07/2001 | CA2368268A1 Porphyrin compounds |
06/07/2001 | CA2360829A1 Nitroimidazole substituted porphyrin complex |
06/07/2001 | CA2327575A1 Combination of aldose reductase inhibitors and antihypertensive agents for the treatment of diabetic complications |
06/06/2001 | EP1104762A1 Substituted imidazo 1,2a]azines as selective inhibotors of cox-2 |
06/06/2001 | EP1104431A1 Metallocenyl-phthalocyanines |
06/06/2001 | EP1104409A1 Process for preparing piperazic acid and its conversion to n-acylated bicyclic rings containing n,n-linkages useful as intermediates for caspase inhibitors |
06/06/2001 | EP0781283B1 Triazolopyridazines process and intermediates for their preparation and their use as medicaments |
06/06/2001 | EP0777659B1 Morpholine derivatives and their use as therapeutic agents |
06/06/2001 | EP0681584B1 Condensed heterocyclic glutamic acid derivatives as antiproliferative agents |
06/06/2001 | CN1298405A Yellow pteridine having a hue-angle of at least 98 |
06/06/2001 | CN1298390A Arylphenyl-substituted cyclic keto-enols |
06/06/2001 | CN1066767C Mixed crystals and solid solutions of 1,4-diketopyrrolopyrroles |
06/06/2001 | CN1066766C Diketopyrrolopyrrole pigment with high chroma |
06/06/2001 | CN1066733C 1-(1,2-disubstituted piperidinyl)-4-(fused imidazole)-piperidine derivatives |
06/05/2001 | US6242609 Ammonium trihalide for halogenation of color couplers and silver halide emulsions |
06/05/2001 | US6242596 Preparation of betamethyl carbapenem intermediates |
06/05/2001 | US6242453 Polycyclo heterocyclic derivatives as antiinflammatory agents |
06/05/2001 | US6242451 Fungicidal trihalophenyl-triazolopyrimidines |
06/05/2001 | US6242444 5-(2,3-dihydro-5-(4-methylpiperazin-1-ylsulfonyl)-7-benzofuryl )-1-methyl-3-propyl-6,7-dihydro-1h-pyrazolo(4,3-d)pyrimidin-7-one, for example; treatment of inter alia erectile dysfunction. |
06/05/2001 | US6242415 Mediation of cytokines by melanin |
06/05/2001 | CA2034592C Crystalline hydrochloride of new beta-lactam antibiotic and process therefor |
05/31/2001 | WO2001038584A2 Non-aggregating, non-quenching oligomers comprising nucleotide analogues; methods of synthesis and use thereof |
05/31/2001 | WO2001038331A2 Pyrazolo[1,5-d][1,2,4]triazines for enhancing cognition |
05/31/2001 | WO2001038325A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/31/2001 | WO2001037629A2 High surface microporous materials which are active in oxidation reactions. tiq-6 and metiq-6 |
05/31/2001 | WO1999064041A9 Multibinding agents that modulate nmda receptors |
05/31/2001 | US20010002422 (3,4,7,8,9,10-hexahydro-6, 10 -6H-pyridazino [1,2-a] [1,2,] diazepine-1-carboxylic-acid derivatives |
05/31/2001 | CA2391103A1 Pyrazolo¬1,5-d|¬1,2,4|triazines for enhancing cognition |
05/31/2001 | CA2390923A1 5-membered n-heterocyclic compounds with hypoglycemic and hypolipidemic activity |
05/30/2001 | EP1103553A2 Substituted heterocyclic derivatives |
05/30/2001 | EP1103551A1 Pyrazole derivatives and salts thereof |
05/30/2001 | EP1102770A1 Paramagnetic 3-,8-substituted deuteroporphyrin derivatives, pharmaceutical preparations containing same, method for producing same and their use in magnetic resonance imaging of necrosis and infarction |
05/30/2001 | EP1102769A2 Tricyclic carboxamides |
05/30/2001 | EP1102751A1 Novel bi- and tri-cyclic aza compounds and their uses |
05/30/2001 | EP1102597A1 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht 4 receptors |
05/30/2001 | EP0752992B1 IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-4-ONE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME |
05/30/2001 | EP0750619B1 Hetero-annulated indazoles |
05/30/2001 | EP0658109B1 Metallo porphyrin compositions |
05/30/2001 | EP0641320B1 Substituted (s)-3-phenylpiperidine derivatives, their preparation and their use as dopamine autoreceptor antagonists |
05/30/2001 | CN1297450A Preparation of alkylthio- and/or arylthio-substd. diketo-diaryl-pyrrolopyrroles |
05/30/2001 | CN1297351A Intermittent claudication therapeutic drugs comprising pyrroloazepines |
05/30/2001 | CN1296949A Process for synthesizing benzoporphyrin zinc complex |
05/30/2001 | CN1066450C Pyrazolo [1,5-1] pyrimidine derivs. |
05/30/2001 | CN1066449C Tricyclic oxime ethers, processes for their preparation and pharmaceutical compositions contg. them |
05/30/2001 | CN1066448C Amide derivs. |
05/30/2001 | CN1066438C Preparation of beta-methyl carbapenem intermediates |
05/29/2001 | US6239175 Carbamoyloxy derivatives of mutiline and their use as antibacterials |
05/29/2001 | US6239133 Imidazoquinoxaline protein tyrosine kinase inhibitors |